Millions worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans. There is no cure, but prevention ...

Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...

Features of immune system ageing can be detected in the earliest stages of rheumatoid arthritis (RA), even before clinical diagnosis, a new study has found which provides at-risk individuals with hope ...

Preclinical rheumatoid arthritis (RA), also known as pre-rheumatoid arthritis (pre-RA), represents the phase of rheumatoid arthritis (RA) development before symptoms appear, i.e., before inflammatory ...

With the discovery of autoantibodies and other risk factors for rheumatoid arthritis (RA), researchers developed clinical trials to see whether the disease can be prevented entirely. In the past 10 ...

NEW YORK, Nov 7 Reuters) - A closely watched experimental drug for rheumatoid arthritis being developed by Pfizer Inc significantly reduced symptoms and improved physical function, according to data ...

Millions of people around the world suffer from rheumatoid arthritis, an autoimmune disorder that causes debilitating joint swelling and pain. Researchers have been looking for ways to identify those ...

Diagnosis of rheumatoid arthritis (RA) is largely clinical, based on key historic and physical findings and serial observation of symptoms, signs and response to therapies. Observation during the ...

A groundbreaking scientific perspective is reshaping how researchers understand rheumatoid arthritis, a debilitating autoimmune condition that affects nearly 1.3 million Americans. Recent studies have ...

BOSTON, Nov. 7 (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday that its experimental rheumatoid arthritis drug, Actemra, was effective in the second of five late-stage clinical trials.